miR-301a displayed significantly higher expression in both lung adenocarcinoma and lung squamous cell carcinoma compared to normal tissue (Fig. 7A), whereas its target genes, SMAD4 was significantly downregulated in lung cancer sample compared to normal tissue (Fig. 7B). This evidence concerns the gene SMAD4 and lung cancer.